{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:16:55Z","timestamp":1789435015382,"version":"build-2803163510"},"reference-count":51,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"funded by the Medical University of Lublin, Poland","award":["DS 474"],"award-info":[{"award-number":["DS 474"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Drug-induced ototoxicity resulting from therapy with aminoglycoside antibiotics and loop diuretics is one of the main well-known causes of hearing loss in patients. Unfortunately, no specific protection and prevention from hearing loss are recommended for these patients. This study aimed at evaluating the ototoxic effects produced by mixtures of amikacin (AMI, an aminoglycoside antibiotic) and furosemide (FUR, a loop diuretic) in the mouse model as the hearing threshold decreased by 20% and 50% using auditory brainstem responses (ABRs). Ototoxicity was produced by the combinations of a constant dose of AMI (500 mg\/kg; i.p.) on FUR-induced hearing threshold decreases, and a fixed dose of FUR (30 mg\/kg; i.p.) on AMI-induced hearing threshold decreases, which were determined in two sets of experiments. Additionally, the effects of N-acetyl-L-cysteine (NAC; 500 mg\/kg; i.p.) on the hearing threshold decrease of 20% and 50% were determined by means of an isobolographic transformation of interactions to detect the otoprotective action of NAC in mice. The results indicate that the influence of a constant dose of AMI on FUR-induced hearing threshold decreases was more ototoxic in experimental mice than a fixed dose of FUR on AMI-induced ototoxicity. Moreover, NAC reversed the AMI-induced, but not FUR-induced, hearing threshold decreases in this mouse model of hearing loss. NAC could be considered an otoprotectant in the prevention of hearing loss in patients receiving AMI alone and in combination with FUR.<\/jats:p>","DOI":"10.3390\/ijms24087596","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T03:01:48Z","timestamp":1682046108000},"page":"7596","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease"],"prefix":"10.3390","volume":"24","author":[{"given":"Marek","family":"Zadro\u017cniak","sequence":"first","affiliation":[{"name":"Department of Otolaryngology and Laryngological Oncology, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Szyma\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Laryngological Oncology, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3059-0393","authenticated-orcid":false,"given":"Jarogniew J.","family":"\u0141uszczki","sequence":"additional","affiliation":[{"name":"Department of Occupational Medicine, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.heares.2006.11.012","article-title":"Prevention of Noise- and Drug-induced Hearing Loss with D-methionine","volume":"226","author":"Campbell","year":"2007","journal-title":"Hear. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S1359-6446(05)03552-X","article-title":"Ototoxicity: Therapeutic Opportunities","volume":"10","author":"Rybak","year":"2005","journal-title":"Drug. Discov. Today"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0378-5955(93)90035-Y","article-title":"Dose-response Relationships for Furosemide Ototoxicity in Rat","volume":"71","author":"Whitworth","year":"1993","journal-title":"Hear. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0378-5955(91)90062-E","article-title":"Cochlear Cultures as a Model System for Studying Aminoglycoside induced Ototoxicity","volume":"53","author":"Richardson","year":"1991","journal-title":"Hear. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10162-009-0206-7","article-title":"Supporting Cell Division is not Required for Regeneration of Auditory Hair Cells after Ototoxic Injury in Vitro","volume":"11","author":"Shang","year":"2010","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Anfuso, C.D., Cosentino, A., Agafonova, A., Zappal\u00e0, A., Giurdanella, G., Trovato Salinaro, A., Calabrese, V., and Lupo, G. (2022). Pericytes of Stria Vascularis Are Targets of Cisplatin-Induced Ototoxicity: New Insights into the Molecular Mechanisms Involved in Blood-Labyrinth Barrier Breakdown. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415790"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"114045","DOI":"10.1016\/j.biopha.2022.114045","article-title":"Cisplatin-induced Ototoxicity: From Signaling Network to Therapeutic Targets","volume":"157","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"110920","DOI":"10.1016\/j.ijporl.2021.110920","article-title":"(-)-Epigallocatechin-3-gallate (EGCG) Prevents Aminoglycosides-induced Ototoxicity via Anti-oxidative and Anti-apoptotic Pathways","volume":"150","author":"Zong","year":"2021","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/ijmm.2017.3003","article-title":"FoxO3a Plays a Key Role in the Protective Effects of Pomegranate Peel Extract against Amikacin-induced Ototoxicity","volume":"40","author":"Liu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1093\/ndt\/gfr211","article-title":"Protective Effect of N-acetylcysteine from Drug-induced Ototoxicity in Uraemic Patients with CAPD Peritonitis","volume":"26","author":"Tokgoz","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/08860220903491224","article-title":"Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD","volume":"32","author":"Tokgoz","year":"2010","journal-title":"Ren. Fail."},{"key":"ref_12","first-page":"2460","article-title":"Protective effect of ethyl pyruvate on amikacin-induced ototoxicity in rats","volume":"26","author":"Ayral","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s00405-014-3207-z","article-title":"Preventing amikacin related ototoxicity with N-acetylcysteine in patients undergoing peritoneal dialysis","volume":"272","author":"Kocyigit","year":"2015","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.toxlet.2016.01.005","article-title":"Galangin prevents aminoglycoside-induced ototoxicity by decreasing mitochondrial production of reactive oxygen species in mouse cochlear cultures","volume":"245","author":"Kim","year":"2016","journal-title":"Toxicol. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1080\/14992027.2018.1460495","article-title":"Current practice of ototoxicity management across the United Kingdom (UK)","volume":"57","author":"Maru","year":"2018","journal-title":"Int. J. Audiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.14639\/0392-100X-1574","article-title":"Acquired sensorineural hearing loss in children: Current research and therapeutic perspectives","volume":"37","author":"Ralli","year":"2017","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.heares.2017.12.004","article-title":"The expression of oxidative stress response genes is modulated by a combination of resveratrol and N-acetylcysteine to ameliorate ototoxicity in the rat cochlea","volume":"358","author":"Pulido","year":"2018","journal-title":"Hear. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1017\/S0022215116000992","article-title":"Prevention of gentamicin ototoxicity with N-acetylcysteine and vitamin A","volume":"130","author":"Aladag","year":"2016","journal-title":"J. Laryngol. Otol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5152\/iao.2015.650","article-title":"N-acetylcysteine Prevents Gentamicin Ototoxicity in a Rat Model","volume":"11","author":"Korkmaz","year":"2015","journal-title":"J. Int. Adv. Otol."},{"key":"ref_20","first-page":"159","article-title":"Protective effect of L-N-acetylcysteine against gentamycin ototoxicity in the organ cultures of the rat cochlea","volume":"52","author":"Maniu","year":"2011","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2473974x221100545","DOI":"10.1177\/2473974X221100545","article-title":"Does N-acetylcysteine Improve Established Hearing Loss in Guinea Pigs?","volume":"6","author":"Gill","year":"2022","journal-title":"OTO Open."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bjorl.2018.08.002","article-title":"Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: A study with hearing tests and scanning electron microscopy","volume":"86","year":"2020","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105354","DOI":"10.1016\/j.tiv.2022.105354","article-title":"N-acetylcysteine protect inner hair cells from cisplatin by alleviated celluar oxidative stress and apoptosis","volume":"81","author":"Wang","year":"2022","journal-title":"Toxicol. In Vitro"},{"key":"ref_24","first-page":"236","article-title":"Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?","volume":"39","author":"Saliba","year":"2010","journal-title":"J. Otolaryngol. Head. Neck Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5935\/0946-5448.20180007","article-title":"Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial","volume":"22","author":"Sarafraz","year":"2018","journal-title":"Int. Tinnitus J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2004.02.007","article-title":"Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model","volume":"193","author":"Muldoon","year":"2004","journal-title":"Hear. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1525-139X.2012.01090.x","article-title":"N-acetylcysteine use for amelioration of aminoglycoside-induced ototoxicity in dialysis patients","volume":"25","author":"Feldman","year":"2012","journal-title":"Semin. Dial."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ten\u00f3rio, M., Graciliano, N.G., Moura, F.A., Oliveira, A.C.M., and Goulart, M.O.F. (2021). N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants, 10.","DOI":"10.3390\/antiox10060967"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/brb3.208","article-title":"N-acetylcysteine (NAC) in neurological disorders: Mechanisms of action and therapeutic opportunities","volume":"4","author":"Harrigan","year":"2014","journal-title":"Brain Behav."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102497","DOI":"10.1016\/j.redox.2022.102497","article-title":"NAC, NAC, Knockin\u2019 on Heaven\u2019s door: Interpreting the mechanism of action of N-acetylcysteine in tumor and immune cells","volume":"57","author":"Kalyanaraman","year":"2022","journal-title":"Redox Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"107916","DOI":"10.1016\/j.pharmthera.2021.107916","article-title":"The mechanism of action of N-acetylcysteine (NAC): The emerging role of H(2)S and sulfane sulfur species","volume":"228","author":"Pedre","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.otohns.2009.07.014","article-title":"Direct drug application to the round window: A comparative study of ototoxicity in rats","volume":"141","author":"Vacas","year":"2009","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1055\/s-0041-1735522","article-title":"Investigational Medicinal Products for the Inner Ear: Review of Clinical Trial Characteristics in ClinicalTrials.gov","volume":"32","year":"2021","journal-title":"J. Am. Acad. Audiol."},{"key":"ref_34","first-page":"375","article-title":"Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity","volume":"15","author":"Rudnick","year":"2014","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"113071","DOI":"10.1016\/j.biopha.2022.113071","article-title":"A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation","volume":"150","author":"Fang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/JCMA.0000000000000708","article-title":"Ameliorative effect of taxifolin on gentamicin-induced ototoxicity via down-regulation of apoptotic pathways in mouse cochlear UB\/OC-2 cells","volume":"85","author":"Lin","year":"2022","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1139\/bcb-2020-0459","article-title":"Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis","volume":"99","author":"Liu","year":"2021","journal-title":"Biochem. Cell. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1111\/jcmm.15345","article-title":"Salvianolic acid B inhibits ototoxic drug-induced ototoxicity by suppression of the mitochondrial apoptosis pathway","volume":"24","author":"Zheng","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pharep.2019.01.002","article-title":"Vitamin C alleviates ototoxic effect caused by coadministration of amikacin and furosemide","volume":"71","author":"Zadrozniak","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jat.3043","article-title":"Protective role of L-ascorbic acid, N-acetylcysteine and apocynin on neomycin-induced hair cell loss in zebrafish","volume":"35","author":"Wu","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"ref_41","unstructured":"(2023, March 20). ClinicalTrial.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05730283?term=NCT05730283&draw=2&rank=1."},{"key":"ref_42","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/00016488209128929","article-title":"Individual variation and mechanism of kanamycin ototoxicity in rabbits","volume":"94","author":"Ohtani","year":"1982","journal-title":"Acta Otolaryngol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2471\/BLT.21.286823","article-title":"Prevention and management of hearing loss in patients receiving ototoxic medications","volume":"100","author":"Lindeborg","year":"2022","journal-title":"Bull. World Health Organ."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: Reporting in vivo experiments: The ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.taap.2016.11.002","article-title":"Single toxin dose-response models revisited","volume":"314","author":"Demidenko","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.vascn.2014.08.006","article-title":"Computational tools for fitting the Hill equation to dose-response curves","volume":"71","author":"Gadagkar","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2006.07.037","article-title":"Arachidonyl-2\u2032-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model","volume":"547","author":"Luszczki","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000114870","article-title":"Interactions of MRZ 2\/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model","volume":"81","author":"Luszczki","year":"2008","journal-title":"Pharmacology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pharep.2019.01.003","article-title":"New derivative of 1,2,4-triazole-3-thione (TP427) potentiates the anticonvulsant action of valproate, but not that of carbamazepine, phenytoin or phenobarbital in the mouse tonic-clonic seizure model","volume":"71","author":"Luszczki","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9.19.1","DOI":"10.1002\/0471141755.ph0919s72","article-title":"Drug combinations: Tests and analysis with isoboles","volume":"72","author":"Tallarida","year":"2016","journal-title":"Curr. Protoc. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/8\/7596\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:19:54Z","timestamp":1760123994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/8\/7596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24087596"],"URL":"https:\/\/doi.org\/10.3390\/ijms24087596","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]}}}